Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SWAIN CJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kulagowski, JJ; Curtis, NR; Swain, CJ; Williams, BJ
      Stereocontrolled syntheses of epimeric 3-aryl-6-phenyl-1-oxa-7-azaspiro[4.5]decane NK-1 receptor antagonist precursors

      ORGANIC LETTERS
    2. Cooper, LC; Chicchi, GG; Dinnell, K; Elliott, JM; Hollingworth, GJ; Kurtz, MM; Locker, KL; Morrison, D; Shaw, DE; Tsao, KL; Watt, AP; Williams, AR; Swain, CJ
      2-aryl indole NK1 receptor antagonists: Optimisation of indole substitution

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Dinnell, K; Chicchi, GG; Dhar, MJ; Elliott, JM; Hollingworth, GJ; Kurtz, MM; Ridgill, MP; Rycroft, W; Tsao, KL; Williams, AR; Swain, CJ
      2-aryl indole NK1 receptor antagonists: Optimisation of the 2-aryl ring and the indole nitrogen substituent

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Shaw, D; Chicchi, GG; Elliott, JM; Kurtz, M; Morrison, D; Ridgill, MP; Szeto, N; Watt, AP; Williams, AR; Swain, CJ
      2-aryl indole NK1 antagonists: Optimisation of the amide substituent

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    5. Harrison, T; Owens, AP; Williams, BJ; Swain, CJ; Williams, A; Carlson, EJ; Rycroft, W; Tattersall, FD; Cascieri, MA; Chicchi, GG; Sadowski, S; Rupniak, NMJ; Hargreaves, RJ
      An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration

      JOURNAL OF MEDICINAL CHEMISTRY
    6. Seward, EM; Swain, CJ
      Neurokinin receptor antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    7. Hollingworth, GJ; Dinnell, K; Dickinson, LC; Elliott, JM; Kulagowski, JJ; Swain, CJ; Thomson, CG
      A convenient method for the preparation of aryl cyclopropyl ethers from phenols

      TETRAHEDRON LETTERS
    8. HARRISON T; KORSGAARD MPG; SWAIN CJ; CASCIERI MA; SADOWSKI S; SEABROOK GR
      HIGH-AFFINITY, SELECTIVE NEUROKININ-2 AND NEUROKININ-3 RECEPTOR ANTAGONISTS FROM A COMMON STRUCTURAL TEMPLATE

      Bioorganic & medicinal chemistry letters
    9. OWENS AP; HARRISON T; MOSELEY JD; SWAIN CJ; SADOWSKI S; CASCIERI MA
      HIGH-AFFINITY PHENYLGLYCINOL-BASED NK1 RECEPTOR ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    10. BOOTH SE; JENKINS PR; SWAIN CJ
      THE PREPARATION AND INTRAMOLECULAR RADICAL CYCLIZATION REACTIONS OF CHIRAL OXIME ETHERS

      Journal of the Brazilian Chemical Society
    11. Swain, CJ
      Neurokinin receptor antagonists

      PROGRESS IN MEDICINAL CHEMISTRY 35
    12. SMITH AL; STEVENSON GI; SWAIN CJ; CASTRO JL
      TRACELESS SOLID-PHASE SYNTHESIS OF 2,3-DISUBSTITUTED INDOLES

      Tetrahedron letters
    13. KRAMER MS; CUTLER N; FEIGHNER J; SHRIVASTAVA R; CARMAN J; SRAMEK JJ; REINES SA; LIU GH; SNAVELY D; WYATTKNOWLES E; HALE JJ; MILLS SG; MACCOSS M; SWAIN CJ; HARRISON T; HILL RG; HEFTI F; SCOLNICK EM; CASCIERI MA; CHICCHI GG; SADOWSKI S; WILLIAMS AR; HEWSON L; SMITH D; CARLSON EJ; HARGREAVES RJ; RUPNIAK NMJ
      DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS

      Science
    14. STEVENSON GI; HUSCROFT I; MACLEOD AM; SWAIN CJ; CASCIERI MA; CHICCHI GG; GRAHAM MI; HARRISON T; KELLEHER FJ; KURTZ M; LADDUWAHETTY T; MERCHANT KJ; METZGER JM; MACINTYRE DE; SADOWSKI S; SOHAL B; OWENS AP
      4,4-DISUBSTITUTED PIPERIDINE HIGH-AFFINITY NK1 ANTAGONISTS - STRUCTURE-ACTIVITY-RELATIONSHIPS AND IN-VIVO ACTIVITY

      Journal of medicinal chemistry
    15. SWAIN CJ; WILLIAMS BJ; BAKER R; CASCIERI MA; CHICCHI G; FORREST M; HERBERT R; KEOWN L; LADDUWAHETTY T; LUELL S; MACINTYRE DE; METZGER J; MORTON S; OWENS AP; SADOWSKI S; WATT AP
      3-BENZYLOXY-2-PHENYLPIPERIDINE NK1 ANTAGONISTS - THE INFLUENCE OF ALPHA-METHYL SUBSTITUTION

      Bioorganic & medicinal chemistry letters
    16. RUPNIAK NMJ; TATTERSALL FD; WILLIAMS AR; RYCROFT W; CARLSON EJ; CASCIERI MA; SADOWSKI S; BER E; HALE JJ; MILLS SG; MACCOSS M; SEWARD E; HUSCROFT I; OWEN S; SWAIN CJ; HILL RG; HARGREAVES RJ
      IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS

      European journal of pharmacology
    17. RUPNIAK NMJ; TATTERSALL FD; WILLIAMS AR; RYCROFT W; CARLSON EJ; CASCIERI MA; HALE JJ; MILLS SG; MACCOSS M; SEWARD E; HUSCROFT I; SWAIN CJ; HILL RG; HARGREAVES RJ
      PREDICTION OF THE ANTIEMETIC ACTIVITY OF NK1 RECEPTOR ANTAGONISTS IN FERRETS BY THEIR ABILITY TO INHIBIT GR73632-INDUCED FOOT TAPPING IN GERBILS

      British Journal of Pharmacology
    18. SWAIN CJ
      THERAPEUTIC PROFILE - NK1 RECEPTOR ANTAGONISTS

      Drug discovery today
    19. SWAIN CJ
      NEUROKININ RECEPTOR ANTAGONISTS

      Expert opinion on therapeutic patents
    20. GWAVAVA O; SWAIN CJ; PODMORE F
      MECHANISMS OF ISOSTATIC COMPENSATION OF THE ZIMBABWE AND KAAPVAAL CRATONS, THE LIMPOPO BELT AND THE MOZAMBIQUE BASIN

      Geophysical journal international
    21. FONG TM; YU H; HUANG RRC; CASCIERI MA; SWAIN CJ
      RELATIVE CONTRIBUTION OF POLAR INTERACTIONS AND CONFORMATIONAL COMPATIBILITY TO THE BINDING OF NEUROKININ-1 RECEPTOR ANTAGONISTS

      Molecular pharmacology
    22. LADDUWAHETTY T; BAKER R; CASCIERI MA; CHAMBERS MS; HAWORTH K; KEOWN LE; MACINTYRE DE; METZGER JM; OWEN S; RYCROFT W; SADOWSKI S; SEWARD EM; SHEPHEARD SL; SWAIN CJ; TATTERSALL FD; WATT AP; WILLIAMSON DW; HARGREAVES RJ
      N-HETEROARYL-2-PHENYL-3-(BENZYLOXY)PIPERIDINES - A NOVEL CLASS OF POTENT ORALLY-ACTIVE HUMAN NK1 ANTAGONISTS

      Journal of medicinal chemistry
    23. SWAIN CJ
      HORIZONTAL ACCELERATION CORRECTIONS IN AIRBORNE GRAVIMETRY

      Geophysics
    24. HARRISON T; OWENS AP; WILLIAMS BJ; SWAIN CJ; BAKER R; HUTSON PH; SADOWSKI S; CASCIERI MA
      PIPERIDINE-ETHER BASED HNK(1) ANTAGONISTS .2. INVESTIGATION OF THE EFFECT OF N-SUBSTITUTION

      Bioorganic & medicinal chemistry letters
    25. OWENS AP; WILLIAMS BJ; HARRISON T; SWAIN CJ; BAKER R; SADOWSKI S; CASCIERI MA
      PHENYL-GLYCINOL BASED NK1 RECEPTOR ANTAGONISTS - TOWARDS THE MINIMUM PHARMACOPHORE

      Bioorganic & medicinal chemistry letters
    26. SWAIN CJ; FONG TM; HAWORTH K; OWEN SN; SEWARD EM; STRADER CD
      QUINUCLIDINE-BASED NK1 ANTAGONISTS, THE ROLE OF THE BENZHYDRYL

      Bioorganic & medicinal chemistry letters
    27. JOHNSON AC; SWAIN CJ
      FURTHER EVIDENCE OF FRACTURE-ZONE INDUCED TECTONIC SEGMENTATION OF THE ANTARCTIC PENINSULA FROM DETAILED AEROMAGNETIC ANOMALIES

      Geophysical research letters
    28. CASCIERI MA; SHIAO LL; MILLS SG; MACCOSS M; SWAIN CJ; YU H; BER E; SADOWSKI S; WU MT; STRADER CD; FONG TM
      CHARACTERIZATION OF THE INTERACTION OF DIACYLPIPERAZINE ANTAGONISTS WITH THE HUMAN NEUROKININ-1 RECEPTOR - IDENTIFICATION OF A COMMON BINDING-SITE FOR STRUCTURALLY DISSIMILAR ANTAGONISTS

      Molecular pharmacology
    29. SWAIN CJ; SEWARD EM; CASCIERI MA; FONG TM; HERBERT R; MACINTYRE DE; MERCHANT KJ; OWEN SN; OWENS AP; SABIN V; TEALL M; VANNIEL MB; WILLIAMS BJ; SADOWSKI S; STRADER C; BALL RG; BAKER R
      IDENTIFICATION OF A SERIES OF 3-(BENZYLOXY)-1-AZABICYCLO[2.2.2]OCTANEHUMAN NK1 ANTAGONISTS

      Journal of medicinal chemistry
    30. FONG TM; HUANG RRC; YU H; SWAIN CJ; UNDERWOOD D; CASCIERI MA; STRADER CD
      MUTATIONAL ANALYSIS OF NEUROKININ RECEPTOR FUNCTION

      Canadian journal of physiology and pharmacology
    31. HARRISON T; WILLIAMS BJ; SWAIN CJ
      GEM-DISUBSTITUTED AMINO-ETHER BASED SUBSTANCE-P ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    32. HARRISON T; WILLIAMS BJ; SWAIN CJ; BALL RG
      PIPERIDINE-ETHER BASED HNK(1) ANTAGONISTS .1. DETERMINATION OF THE RELATIVE AND ABSOLUTE STEREOCHEMICAL REQUIREMENTS

      Bioorganic & medicinal chemistry letters
    33. SWAIN CJ; CASCIERI MA; OWENS A; SAARI W; SADOWSKI S; STRADER C; TEALL M; VANNIEL MB; WILLIAMS BJ
      ACYCLIC NK1 ANTAGONISTS - REPLACEMENTS FOR THE BENZHYDRYL GROUP

      Bioorganic & medicinal chemistry letters
    34. WILLIAMS BJ; TEALL M; MCKENNA J; HARRISON T; SWAIN CJ; CASCIERI MA; SADOWSKI S; STRADER C; BAKER R
      ACYCLIC NK-1 ANTAGONISTS - 2-BENZHYDRYL-2-AMINOETHYL ETHERS

      Bioorganic & medicinal chemistry letters
    35. BOOTH SE; JENKINS PR; SWAIN CJ; SWEENEY JB
      INTRAMOLECULAR ADDITION OF VINYL AND ARYL RADICALS TO OXIME ETHERS INTHE SYNTHESIS OF 5-MEMBERED, 6-MEMBERED AND 7-MEMBERED RING-SYSTEMS

      Journal of the Chemical Society. Perkin transactions. I
    36. SWAIN CJ; MAGUIRE PKH; KHAN MA
      GEOPHYSICAL EXPERIMENTS AND MODELS OF THE KENYA RIFT BEFORE 1989

      Tectonophysics
    37. MAGUIRE PKH; SWAIN CJ; MASOTTI R; KHAN MA
      A CRUSTAL AND UPPERMOST MANTLE CROSS-SECTIONAL MODEL OF THE KENYA RIFT DERIVED FROM SEISMIC AND GRAVITY-DATA

      Tectonophysics
    38. MACLEOD M; MERCHANT KJ; BROOKFIELD F; KELLEHER F; STEVENSON G; OWENS AP; SWAIN CJ; BAKER R; CASCIERI MA; SADOWSKI S; BER E; STRADER CD; MACINTYRE DE; METZGER JM; BALL RG
      IDENTIFICATION OF L-TRYPTOPHAN DERIVATIVES WITH POTENT AND SELECTIVE ANTAGONIST ACTIVITY AT THE NK1 RECEPTOR

      Journal of medicinal chemistry
    39. CASCIERI MA; MACLEOD AM; UNDERWOOD D; SHIAO LL; BER E; SADOWSKI S; YU H; MERCHANT KJ; SWAIN CJ; STRADER CD; FONG TM
      CHARACTERIZATION OF THE INTERACTION OF N-ACYL-L-TRYPTOPHAN BENZYL ESTER NEUROKININ ANTAGONISTS WITH THE HUMAN NEUROKININ-1 RECEPTOR

      The Journal of biological chemistry
    40. FONG TM; YU H; CASCIERI MA; UNDERWOOD D; SWAIN CJ; STRADER CD
      THE ROLE OF HISTIDINE-265 IN ANTAGONIST BINDING TO THE NEUROKININ-1 RECEPTOR

      The Journal of biological chemistry
    41. FONG TM; YU H; CASCIERI MA; UNDERWOOD D; SWAIN CJ; STRADER CD
      INTERACTION OF GLUTAMINE-165 IN THE 4TH TRANSMEMBRANE SEGMENT OF THE HUMAN NEUROKININ-1 RECEPTOR WITH QUINUCLIDINE ANTAGONISTS

      The Journal of biological chemistry
    42. SWAIN CJ; SEWARD EM; SABIN V; OWEN S; BAKER R; CASCIERI MA; SADOWSKI S; STRADER C; BALL RG
      QUINUCLIDINE BASED NK-1 ANTAGONISTS .2. DETERMINATION OF THE ABSOLUTESTEREOCHEMICAL REQUIREMENTS

      Bioorganic & medicinal chemistry letters
    43. SEWARD EM; SWAIN CJ; MERCHANT KJ; OWEN SN; SABIN V; CASCIERI MA; SADOWSKI S; STRADER C; BAKER R
      QUINUCLIDINE-BASED NK-1 ANTAGONISTS .1. 3-BENZYLOXY-1-AZABICYCLO[2.2.2]OCTANES

      Bioorganic & medicinal chemistry letters
    44. MACLEOD AM; MERCHANT KJ; CASCIERI MA; SADOWSKI S; BER E; SWAIN CJ; BAKER R
      N-ACYL-L-TRYPTOPHAN BENZYL-ESTERS - POTENT SUBSTANCE-P RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    45. SWAIN CJ; BAKER R; KNEEN C; HERBERT R; MOSELEY J; SAUNDERS J; SEWARD EM; STEVENSON GI; BEER M; STANTON J; WATLING K; BALL RG
      NOVEL 5-HT3 ANTAGONISTS - DOL-3-YLSPIRO(AZABICYCLOALKANE-3,5'(4'H)-OXAZOLES)

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 16:37:09